Research Article

Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

Figure 3

Forest plot of the odds of VTE in ovarian cancer patients that have serous histology tumors (versus nonserous histologies). This figure shows the pooled odd of serous histology (versus nonserous histology). The total pooled odds are 1.26 (0.91–1.75).